|
SYNTHES GMBH RFNA/ 12MM/ 200MM/ STANDARD BEND/ STER; ROD, FIXATION, INTRAMEDULLARY AND ACCESSORIES
|
Back to Search Results |
|
| Catalog Number |
04.233.220S |
| Medical Device Problem Code |
Migration (4003)
|
| Health Effect - Clinical Code |
Insufficient Information (4580)
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.H10 additional narrative: b3: unknown date when device migrated.D9: complainant part is not expected to be returned for manufacturer review/investigation.E3: reporter is a j&j sales representative.H3, h6: the investigation could not be completed; no conclusion could be drawn, as no product was received.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Event or Problem Description
|
|
Several allegations were reported in post market study id: depuy - (b)(6); subject id: (b)(6).It was reported a retrograde femoral nail advanced (rfna) migration occurred on an unknown date.Date of initial injury was (b)(6) 2023 and due to a high trauma event resulting in a right femur 32c multi fragment shaft fracture and periprosthetic fracture.Initial surgery was completed on (b)(6) 2023.A nail and 3 screws were implanted.On (b)(6) 2024 it was noted in the study that the nail had migrated and revision surgery was required.This report is for one rfna/ 12mm/ 200mm/ standard bend/ ster nail for (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Manufacturing location: monument, manufacturing date: 21-jun-2023, expiration date: 31-may-2028, part number: 04.233.220s, 12mm/rfn/200mm/ 5 ang/ster/poly inlay, lot number: 6652p78 (sterile).One piece scrapped at op #30, mill holes and profiles, for dropped part.Production order traveler met all inspection acceptance criteria apart from the one piece noted.Inspection certificate 04.233.216s-12-btq902734 / 3 met all inspection acceptance criteria apart from the one piece noted.Packaging label log (pll) and lmd rev d were reviewed and determined to be conforming.Packaging boms were reviewed and determined to be conforming with no deviations to normal packaging identified.Scn 25982 supplied by (b)(4) (albq) was reviewed and determined to be conforming this lot met all dimensional and visual criteria at the time of release with no issues documented during the manufacture that would contribute to this complaint condition.Component part(s) reviewed: component parts were not reviewed as the reported complaint condition of ¿screw migration¿ does not indicate breakage of the nail or any of its components.Therefore, review of the raw materials would not be pertinent to the reported complaint condition.This lot met all dimensional, visual, packaging criteria at the time of release with no issues documented during the manufacture that would contribute to this complaint condition.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Search Alerts/Recalls
|
|
|